| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC45
|
|
|
|
|
| Submitter :
|
| Mrs. Theresa Lohman
|
| Date & Time:
|
| 09/01/2005 04:09:33
|
|
|
|
|
| Organization :
|
| Planned Parenthood
|
|
|
|
|
| Category :
|
| Health Professional
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| 2
|
|
|
|
|
|
|
|
| A. If FDA limited sale of an OTC product to a particular subpopulation, e.g., by making the product available to the subpopulation by prescription only, would FDA be able to enforce such a limitation as a matter of law?
|
|
|
|
|
|
|
|
|
|
|
| Possibly if the consumer had to ask for it (at the pharmacy counter) and show picture ID to purchase it.
|
|
|
|
|
|
|
|
| B. If it could, would it be able to do so as practical matter and, if so, how?
|
|
|
|
|
|
|
|
| See above
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|